The questions being asked in immunology, inflammation biology, and drug discovery are bigger, and so is the scrutiny on data quality. Yet for many labs, getting reliable, reproducible measurements of immune signaling molecules remains a daily friction point.
Key takeaways:
- Immune signaling quantification faces intensifying reproducibility demands and common detection gaps. VICTOR Kira™ multimode plate reader and BioLegend LEGEND MAX™ kits address these challenges:
- R2 = 0.99 across all 10 standard curves, covering eight human and two mouse immune markers.
- Monochromator-based optics, OD range up to 4.0, integrated plate shaking, and temperature control equip VICTOR Kira reader to handle the broad range of ELISA measurement requirements to enhance workflow.
- 10 application briefs covering kit components, measurement settings, standard curves, and sample data that can help researchers evaluate method fit by analyte, species, and concentration range.
The research landscape
Demand for accurate immune signaling data has grown sharply alongside the expansion of immuno-oncology, autoimmune disease research, and inflammation biology.
Checkpoint inhibitors, CAR-T therapies, and bispecific antibodies have made immune profiling routine in oncology. Cytokines such as IL-1β, IL-6, TNF-α, and IL-2 are established therapeutic targets, while IL-8 (CXCL8) is attracting increasing attention in tumor microenvironment and neutrophil research. Mouse models also remain essential, with researchers routinely measuring corresponding analytes across human and mouse samples.
At the same time, expectations for reproducibility continue to rise. Funding agencies, journals, and regulatory bodies demand rigorous, well-documented data, placing greater importance on the reliability of laboratory instruments, reagents, and workflows.
Common detection gaps
- Wavelength flexibility: Monochromator-based optics offer native dual-wavelength ELISA correction without filter changes
- Low-end sensitivity: Targets with low concentration ranges, such as TGF-β, require detection systems with minimal background noise and high signal-to-noise performance to produce accurate quantification near the assay's lower detection limits
- Run-to-run variability: Temperature fluctuations and uneven mixing accumulate across a busy lab day, but the VICTOR Kira reader offers optional uniform temperature control and shaking functions that can be added to produce consistent results
Putting it to the test: 10 immune markers, one workflow
The VICTOR Kira multimode plate reader was paired with LEGEND MAX ELISA kits across a panel of 10 biologically diverse immune signaling molecules.
Click on the analyte name, below, to read the full application brief.
| Analyte | Species | Biological context | Sample OD | Calculated concentration |
|---|---|---|---|---|
| Granzyme B | Human | Cytotoxic T cell activity, tumor immunity | 0.120 (duplicate) | 29.14 pg/mL |
| IFN-y | Human | T cell activation, antiviral/antitumor response | 1.268 / 0.805 | 241.64 / 147.73 pg/mL |
| IL-1β | Human | Innate immunity, inflammasome activation | 0.740 / 0.770 | 30.38 / 31.69 pg/mL |
| IL-2 | Human | T cell proliferation, immune regulation | 0.147 / 0.208 | 57.30 / 90.71 pg/mL |
| IL-6 | Human | Acute phase response, inflammation, disease progression | 0.740 / 0.742 | 73.01 / 73.54 pg/mL |
| IL-8 | Human | Neutrophil recruitment, tumor microenvironment | 0.517 | 111.1 pg/mL |
| Latent TGF-β | Human | Immune suppression, fibrosis, tumor evasion | 0.082 / 0.043 | 25.33 / 13.54 pg/mL |
| TNF-α | Human | Pro-inflammatory signaling, therapeutic target | 0.079 | 113.4 pg/mL |
| IFN-γ | Mouse | Immune activation, antitumor models | 0.314 | 503.90 pg/mL |
| IL-6 | Mouse | Inflammation and disease models | 1.113 / 1.111 | 145.59 / 145.19 pg/mL |
Result: R2 = 0.99 for every standard curve, across every analyte, across both species
The IL-1β duplicates (30.38 / 31.69 pg/mL) and mouse IL-6 duplicates (145.59 / 145.19 pg/mL) demonstrate tight within-run reproducibility. Latent TGF-β results at 13.54 and 25.33 pg/mL confirm accuracy at the very low end of the dynamic range.
Conclusion
Immune signaling quantification will only grow in importance as immuno-oncology matures and reproducibility demands intensify. What this 10-analyte series demonstrates is that the tools to meet that standard are accessible. You need an instrument with the right optical architecture and a kit system with reliable, consistent reagents.
When those two are well-matched, the data takes care of itself.
For research use only. Not for use in diagnostic procedures.
